Akari Therapeutics Plc Overview
Akari Therapeutics Plc Discounted Cash Flow
DCF Analysis for AKTX.
Get informed when a big investor buys or sells
+ FollowFair Value
$5.29
Current Fair Value
$5.29
↓ 51.7% Downside
Overvalued by 51.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison